EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 253 filers reported holding EMERGENT BIOSOLUTIONS INC in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $62 | -69.6% | 18,195 | -34.3% | 0.00% | – |
Q2 2023 | $204 | -16.7% | 27,690 | +17.2% | 0.00% | – |
Q1 2023 | $245 | -8.6% | 23,631 | +4.0% | 0.00% | – |
Q4 2022 | $268 | -100.0% | 22,717 | -19.3% | 0.00% | – |
Q3 2022 | $592,000 | -85.7% | 28,139 | -78.8% | 0.00% | -100.0% |
Q2 2022 | $4,126,000 | -60.1% | 132,927 | -47.2% | 0.00% | 0.0% |
Q1 2022 | $10,334,000 | -12.6% | 251,689 | -7.5% | 0.00% | 0.0% |
Q4 2021 | $11,827,000 | -56.3% | 272,073 | -49.7% | 0.00% | -66.7% |
Q3 2021 | $27,065,000 | -22.4% | 540,549 | -2.4% | 0.00% | 0.0% |
Q2 2021 | $34,899,000 | -51.5% | 554,036 | -28.5% | 0.00% | -57.1% |
Q1 2021 | $72,010,000 | -7.9% | 775,054 | -11.2% | 0.01% | -12.5% |
Q4 2020 | $78,164,000 | -14.6% | 872,367 | -1.5% | 0.01% | -27.3% |
Q3 2020 | $91,527,000 | +32.4% | 885,771 | +1.3% | 0.01% | +22.2% |
Q2 2020 | $69,148,000 | +35.3% | 874,402 | -1.0% | 0.01% | +12.5% |
Q1 2020 | $51,123,000 | +6.6% | 883,570 | -0.6% | 0.01% | +33.3% |
Q4 2019 | $47,980,000 | +5.4% | 889,339 | +2.2% | 0.01% | 0.0% |
Q3 2019 | $45,511,000 | +15.8% | 870,528 | +7.0% | 0.01% | 0.0% |
Q2 2019 | $39,287,000 | -4.7% | 813,233 | -0.3% | 0.01% | 0.0% |
Q1 2019 | $41,207,000 | -9.2% | 815,657 | +6.6% | 0.01% | -25.0% |
Q4 2018 | $45,364,000 | -5.7% | 765,254 | +4.7% | 0.01% | +14.3% |
Q3 2018 | $48,106,000 | +55.6% | 730,762 | +19.3% | 0.01% | +40.0% |
Q2 2018 | $30,925,000 | +76.2% | 612,489 | +83.8% | 0.01% | +66.7% |
Q1 2018 | $17,547,000 | +2562.7% | 333,282 | +2248.7% | 0.00% | – |
Q4 2017 | $659,000 | +14.8% | 14,190 | -0.1% | 0.00% | – |
Q3 2017 | $574,000 | +19.1% | 14,200 | 0.0% | 0.00% | – |
Q2 2017 | $482,000 | +17.0% | 14,200 | +0.1% | 0.00% | – |
Q1 2017 | $412,000 | -11.6% | 14,190 | +0.1% | 0.00% | – |
Q4 2016 | $466,000 | +47.9% | 14,180 | +42.1% | 0.00% | – |
Q3 2016 | $315,000 | +21.2% | 9,980 | -27.0% | 0.00% | – |
Q3 2013 | $260,000 | – | 13,673 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |